drugset / Trial / NCT06107153

Effect of Short-term Basal Insulin Initiation in Newly Diagnosed Type 2 Diabetes on 1-year Glycemic Control

NCT06107153

Phase 3 Completed 243 enrolled University of Basrah
Non-randomizedParallel-groupOpen-labelTreatment

Summary

In this study, we aim to explore the beneficial effect of early short-term (two weeks), self-titrated, basal-only insulin therapy on the degree of glycemic control over 1-year follow through a prospective cohort.

Timeline

Start
2023-11-01
Primary completion
2024-11-01
Completion
2024-11-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator insulin glargine Protein / enzyme biologic 10 iu
Comparator Metformin Small molecule 1000 mg
Comparator Pioglitazone Small molecule 30 mg
Comparator SAXAGLIPTIN ANHYDROUS Small molecule 2.5 mg